Tucuvi, a Madrid-based HealthTech firm innovating licensed voice AI, raised €17 million ($20 million) in Sequence A funding to speed up the adoption of its AI-based care administration platform in healthcare programs.
The spherical was led by Cathay Innovation and Kfund, by means of its early-growth fund Leadwind, with participation from present buyers Frontline Ventures, Seaya Ventures, and Shilling.
“Healthcare is underneath monumental strain, and partial options are now not sufficient,” explains María González, CEO of Tucuvi. “To proceed offering high quality care at scale, healthcare programs want AI they will belief: safe, auditable, and designed for actual medical environments. We’re proud to already be working with greater than 60 healthcare organisations and proceed to develop to fulfill growing demand.” (Translated).
Tucuvi’s Sequence A spherical could be located inside a wider, nonetheless comparatively selective circulation of European capital into AI-driven healthcare platforms throughout 2025–2026.
In early 2025, Warsaw-based major care startup Jutro Medical raised €12 million in a Sequence A spherical to develop its community of bodily clinics and deploy medical AI brokers throughout telemedicine and operational workflows. This was adopted later within the 12 months by a €24 million Series A extension, also reported by EU-Startups, to additional scale its AI-first major care mannequin and automation capabilities throughout medical and administrative features.
In opposition to this backdrop, Tucuvi’s Madrid-based give attention to licensed voice AI and end-to-end care administration workflows displays a parallel method to addressing workforce shortages and care complexity, albeit by means of software program deployed instantly into present healthcare programs quite than by means of direct care supply.
Taken collectively, the roughly €53 million raised throughout these bulletins factors to a rising, although nonetheless concentrated, degree of funding in European healthcare AI corporations in search of to extend care capability and operational effectivity by means of automation.
“The Tucuvi platform transforms protocols and medical tips into actual, dependable, and constant AI workflows, permitting us to work together with all our sufferers and enabling our nursing crew to commit their experience to circumstances that require high-value medical judgment,” provides an unidentified Medical Director. (Translated).
Healthcare programs are dealing with growing strain from a scarcity of pros, rising demand for care, and better operational complexity. Tucuvi was based in 2019 to reply to this context with safe, auditable, and autonomous AI brokers that purpose to develop care capability with out compromising medical high quality or belief.
The corporate has developed an AI-powered Care Administration platform designed to automate and orchestrate high-volume care workflows from begin to end.
The platform is predicated on AI brokers, together with LOLA, a voice-based AI agent that conducts safe telephone conversations with sufferers, executes medical and care coordination workflows, and escalates to human groups when mandatory.
Tucuvi at the moment helps greater than 50 workflows, starting from post-surgical follow-up and discharge to power illness administration, preoperative assessments, check preparation, screening applications, appointment scheduling, and demand administration.
Tucuvi’s voice AI brokers deal with telephone interactions, whereas the platform as an entire takes care of workflow logic, referrals, documentation, and integration with present healthcare system operations.
“What satisfied us at Cathay Innovation is Tucuvi’s skill to mix medical rigor, regulatory credibility, and real-world scalability in a single platform,” mentioned Jacky Abitbol, Managing Accomplice at Cathay Innovation. “Its method permits healthcare organisations to deploy autonomous AI with confidence, liberating up vital capability for care groups whereas sustaining the best ranges of security and high quality. We consider Tucuvi is blazing a brand new path in how AI could be responsibly built-in into healthcare operations.”
Tucuvi is reportedly the primary AI platform to acquire European regulatory approval as a Class IIb Software program as a Medical Gadget (SaMD) for each its voice agent and affected person administration platform.
The corporate outlines that their platform has generated constant and measurable leads to collaborating healthcare programs, together with:
- As much as 80% automation of nursing follow-up flows
- Affected person attain and adherence better than 90%, even in extremely advanced populations
- Improved outcomes in power ailments, corresponding to a 5.5% discount in readmissions for COPD
With this funding, Tucuvi will speed up its progress technique in Europe and the USA, develop its AI capabilities, and proceed to evolve its platform as a complete motion and intelligence system for care groups.
